Department of Medicine
University of Pittsburgh
Select a Division
Cardiology
Center for Clinical Pharmacology
Endocrinology and Metabolism
Gastroenterology, Hepatology and Nutrition
General Internal Medicine
Geriatric Medicine
Hematology/Oncology
Infectious Diseases
Pulmonary, Allergy and Critical Care Medicine
Renal-Electrolyte
Rheumatology and Clinical Immunology
Academic Resources
Home
Faculty
Clinical Practice
Educational & Training Programs
Research
Annual Report
Contact Us
Other Resources
Department of Medicine
Divisions of the Department
Internal Medicine Residency Training
Video -"Pittsburgh. A New Vision. A New Tomorrow."
Division of Endocrinology and Metabolism
200 Lothrop Street
E1140 BST
Pittsburgh, PA 15213
Administrative/Research Office: (412) 648-9770
Patient/Clinical Inquiries: (412) 586-9700
Andrew F. Stewart, MD
Chief, Division of Endocrinology and Metabolism
Professor of Medicine
Office:
E1140 Biomedical Science Tower
200 Lothrop Street
Pittsburgh, PA 15261
Phone:
412-648-8630
Fax:
412-648-3290
E-mail:
stewarta@pitt.edu
Education
B.S., Trinity College, 1970
M.D., Columbia Univ., College of Physicians & Surgeons, 1974
Training
Internship, Roosevelt Hospital, New York, NY, 1975
Residency, Roosevelt Hospital, New York, NY, 1977
Fellowship, Yale-New Haven Hospital, New Haven, CT, 1980
Area of Specialization/Research Interest
Vascular actions of PTHrP
Therapy for arterial re-stenosis
Human in vivo pathophysiology of PTHrP
PTHrP and osteoporosis therapy
Physiologic and therapeutic effects of PTHrP &
Hepatocyte growth factor on pancreatic islet
Profile
Dr. Stewart is a Professor of Medicine and is Chief of the Division of Endocrinology at Pitt and UPMC. His research focuses on mechanisms and growth factors that can induce pancreatic beta cells to proliferate, while retaining full function and deploying this growth factors and cell cycle regulators to improving pancreatic beta cells in humans with Type 1 and Type 2 diabetes. His research is supported by the NIH.
Recent Grants
Title:
Combined HGF and VEGF for islet transplantation.
Role:
PI
Amount:
$100,000/yr
Funding Agency:
JDRF
Start Year:
2005
End Year:
2006
Title:
Training in diabetes and endocrinology.
Role:
PI
Amount:
$177,000/yr
Funding Agency:
NIH (T32)
Start Year:
2005
End Year:
2010
Title:
Pure anabolic skeletal therapy with PTH-related protein for myeloma bone disease.
Role:
PI, Proj. 3
Amount:
$120,000/yr
Funding Agency:
MMRF
Start Year:
2004
End Year:
2007
Title:
Islet allograft gene therapy in diabetes.
Role:
PI
Amount:
$500,000/yr
Funding Agency:
NIH/NIDDK (R31)
Start Year:
2003
End Year:
2006
Title:
Pathophysiology of PTH-related protein (1-36) in humans.
Role:
PI
Amount:
$256,000/yr
Funding Agency:
NIH/NIDDK
Start Year:
1996
End Year:
2008
For Pub Med search results,
click here
.